Clearmind Medicine Completes Dosing for Part A of its of FDA-Regulated Phase I/II Clinical Trial
Go back to Clearmind Medicine Completes Dosing for Part A of its of FDA-Regulated Phase I/II Clinical Trial| (NASDAQ: CMND) | Delayed: 1.16 -0.54 (31.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.70 | 52 Week High | $ | |||
| Open | $1.50 | 52 Week Low | $ | |||
| Day High | $1.56 | P/E | N/A | |||
| Day Low | $1.16 | EPS | $ | |||
| Volume | 15,512,723 | |||||
